Fig. 5.
Comparison of trends in CD2 saturation between those who do and do not develop EBV-LPD (P = 0.03) with more sizable changes from baseline for the post-cycle 1and post-cycle 2 measurements for those who develop EBV-LPD.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.